Ipamorelin
5mg
Ipamorelin is a selective growth-hormone secretagogue, a pentapeptide that agonises the ghrelin receptor. Research shows it drives growth-hormone release with little effect on cortisol or prolactin, which makes it one of the cleanest, most selective GH secretagogues studied and a frequent partner to CJC-1295 in synergy research. It remains one of the most-referenced compounds in endocrinology. Supplied as lyophilised powder and released against a third-party HPLC certificate on this page. In-vitro research use only.
Published research on Ipamorelin is indexed on PubMed. See our full UK buyer's guide for Research Peptides.
Intended Use: Strictly for in-vitro laboratory research. Not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics. This product has not been evaluated by the MHRA or FDA. Buyer assumes full responsibility for safe handling and regulatory compliance.
98%+
Purity
LAB
Certified
SAME
Day Ship
Quantity
Add £25.01 more for free UK delivery
Damaged or lost? Free reshipment guaranteed
CJC-1295 + Ipamorelin 5+5mg
Pre-blended GHRH + GHRP vial: CJC-1295 (no DAC) with Ipamorelin.
All components in a single lyophilised vial. One reconstitution, one inventory line, one CoA.
Research Use Only
This product is intended strictly for research and laboratory use only. Not for human consumption, medical use, or diagnostic purposes.
Certificate of Analysis
Third-party tested
Lyophilised Stability
24 months
Sealed at -20°C, light-protected
Reconstituted Stability
Up to 3 months
Stored at 2-8°C after mixing
Cold-Chain Shipping
Always
Dry-cold pack, Royal Mail Tracked 24
Important Notice
All compounds are sold individually and do not include research supplies. Products are provided in lyophilised (powder) form and require proper reconstitution before use in research settings.
Related Products
Product Specifications
Research Overview
Ipamorelin is a synthetic pentapeptide and one of the most selective growth hormone secretagogues (GHS) available. It mirrors the endogenous hormone ghrelin, binding the growth hormone secretagogue receptor type 1a (GHS-R1a) in the anterior pituitary. Its defining trait is precision: unlike growth hormone releasing peptides such as GHRP-2 and GHRP-6, Ipamorelin drives GH release without meaningfully lifting cortisol, prolactin, or ACTH. That clean profile makes it the most specific GHS on the bench for endocrine research, stripping out confounding hormonal variables from experimental designs. Early clinical work by Novo Nordisk looked at Ipamorelin as a candidate for postoperative ileus, weighing its effect on gastrointestinal motility alongside GH secretion. In current practice it is frequently paired with CJC-1295 (modified GRF 1-29) to study synergistic GH release, with Ipamorelin acting at the GHS receptor and CJC-1295 at the GHRH receptor, so that two complementary pathways combine to amplify pulsatile GH output.
Product Specifications
Laboratory Handling
- Store lyophilised vials at -20°C. Refrigerate reconstituted Ipamorelin at 2-8°C and use within 4 weeks.
- Reconstitute with bacteriostatic water, aiming the stream down the side of the vial and swirling gently.
- Handle under aseptic conditions with sterile syringes, wiping the stopper with an alcohol swab before each use.
- Avoid repeated freeze-thaw cycles by preparing single-use aliquots wherever possible to keep the peptide intact.
Frequently Asked Questions
Ipamorelin
5mg · £19.99